Table 2.

Short-term outcome.

Character	NO (%) 410 (100%) Or Median(range)
Early (≤6 months post Kasai) complications Infection Cholangitis UTI Chest infection Wound infection Abdominal collection Ascites Intestinal leak Bile leak Intestinal obstruction PHN Bleeding GO varices Encephalopathy	187 (45.6%) 172 (42%) 108 (26.3%) 26 (6.3%) 85 (20.7%) 54 (13.2%) 64 (15.6%) 49 (12%) 8 (2%) 7 (1.7%) 5 (1.2%) 54 (13.2%) 8 (2%) 30 (7.3%)
CDS of early complications II III V	112 (27.3%) 7 (1.7%) 68 (16.6%)
Post operative bilirubin level TB at 1 month (mg/dL) (Median(range)) DB at 1 month (mg/dL) (Median(range)) TB at 3 months (mg/dL) (Median(range)) DB at 3 month(mg/dL) (Median(range)) TB at 6 month (mg/dL) (Median(range)) DB at 6 month (mg/dL) (Median(range)) Jaundice clearance at 6 months	8(0.6–19) 5.5(0.3–16) 7(0.4–19.1) 5.05(0.2–15) 6 (0.3–17.7) 4.5(0.1–16) 138 (33.7%)
Early patient(≤6 months) mortality The main cause of death Sepsis Liver failure GIT bleeding Aspiration pneumonia ARDS MOF	70 (17.1%) 34 (8.3%) 25 (6.1%) 8 (2%) 1 (0.2%) 1 (0.2%) 1 (0.2%)
LT before or at 6months post-Kasai	3 (0.7%)
Early (6 months) NLS Early (6 months) NLS (months) (Median(range)) Early (6 months) overall survival(NLS ± TLS) Early (6 months) overall survival (months) (Median(range))	339 (82.7%) 6(0.2–6) 340 (82.9%) 6(0.2–6)

UTI: Urinary tract infection, PHN: Portal hypertension, GO: Gastro-esophageal, CDS: Calvien Dindo system, TB: Total bilirubin, DB: Direct bilirubin, GIT: Gastrointestinal system, ARDS: Adult respiratory distress syndrome, MOF: Multi-organ failure, LT: Liver transplantation, NLS: Native liver survival, TLS: Transplanted liver survival.